NCT06517914View on ClinicalTrials.gov

A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

July 29, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Healthy Participants

Interventions

DRUG

YH35995

Oral administration of YH35995

DRUG

Placebo

Oral administration of Placebo

Trial Locations (1)

13496

RECRUITING

CHA Bundang Medical Center, Seongnam

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY